LOVELAND, Colo., Sept. 9, 2021 /PRNewswire/ — Heska Corporation (NASDAQ: HSKA – News; “Heska” or the “Company”), a leading global provider of advanced veterinary diagnostic and specialty products, announced today that the Company has acquired majority ownership of Biotech Laboratories U.S.A. LLC (“Biotech”), an leading developer of rapid assay diagnostics testing, from Biotech Holdings U.S.A. LLC (“Acquisition”).
Founded in 2016 and headquartered in Rockville, Maryland, Biotech develops a full line of rapid point-of-care tests to detect antigens and antibodies associated with infectious and parasitic diseases of animals. Biotech is led by a team of scientists and industry experts with over 100 collective years of disease diagnostic research, development and operations. Biotech lateral flow tests are fast, accurate, and convenient; the products boast excellent specificity, sensitivity, and consistency, as well as mobile reader, extended shelf life, and easy storage capabilities. With a steadfast commitment to innovation and clinical research and development, Biotech aims to support healthier animals by providing high-quality diagnostic solutions to veterinarians, livestock producers, and pet owners worldwide.
“With today’s acquisition of Biotech, we make a big step forward in our Heska-owned global products line and intellectual property portfolio,” commented Heska’s Chief Executive Officer and President, Kevin Wilson. “We have been working for years to enter the market…
